Biotechnologies Aramis Inc.

$40,000,000.00 CAD

≈ $0.97 for every person in Canada ≈ 517 Canadians' average pay for a year

Department: Innovation, Science and Economic Development Canada
Program: SIF Stream 1 - R&D
Recipient country: Canada
Fiscal year: 2024-2025
Agreement period: May 3, 2024 – April 30, 2046
Reference: ic:033-2024-2025-Q1-820045

Published purpose

This project will advance the development of a plant-based influenza vaccine candidate and continue to grow and enhance its world-leading virus-like particle technology platform in Quebec, Canada. The project consists of restarting the acquired Medicago pilot facility The project’s work phase is scheduled to end on December 31, 2026.

In plain English AI-generated

This federal contribution supports Biotechnologies Aramis Inc. in developing plant-based influenza vaccine production in Canada.

Category: Health Primarily funds activity in Canada

Based on the published description. See how AI categorization works — the linked official record is authoritative.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful

View official source record Imported August 3, 2026 from open.canada.ca Grants & Contributions